Kezar Life Sciences, Inc. (KZR): Price and Financial Metrics
GET POWR RATINGS... FREE!
KZR Stock Price Chart Interactive Chart >
KZR Price/Volume Stats
| Current price | $7.17 | 52-week high | $18.55 |
| Prev. close | $7.00 | 52-week low | $4.30 |
| Day low | $6.92 | Volume | 516,664 |
| Day high | $7.18 | Avg. volume | 665,618 |
| 50-day MA | $6.99 | Dividend yield | N/A |
| 200-day MA | $8.12 | Market Cap | 490.27M |
Kezar Life Sciences, Inc. (KZR) Company Bio
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Its lead product candidate, KZR-616, a selective immunoproteasome inhibitor that is in Phase 1b/2 clinical trials in lupus and lupus nephritis The company was incorporated in 2015 and is headquartered in South San Francisco, California.
Latest KZR News From Around the Web
Below are the latest news stories about KEZAR LIFE SCIENCES INC that investors may wish to consider to help them evaluate KZR as an investment opportunity.
As The Stock Falls By -8.81% Year-To-Date, Kezar Life Sciences Inc. (NASDAQ: KZR)’S Stock Continues To Progress In 2023During the last session, Kezar Life Sciences Inc. (NASDAQ:KZR)’s traded shares were 0.51 million, with the beta value of the company hitting 0.23. At the end of the trading day, the stock’s price was $6.42, reflecting an intraday gain of 2.72% or $0.17. The 52-week high for the KZR share is $18.55, that puts it … As The Stock Falls By -8.81% Year-To-Date, Kezar Life Sciences Inc. (NASDAQ: KZR)’S Stock Continues To Progress In 2023 Read More » |
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)SOUTH SAN FRANCISCO, Calif., January 13, 2023--Kezar Life Sciences, Inc., (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company’s Board of Directors granted two employees nonqualified stock options to purchase 65,000 shares of its common stock with an exercise price of $6.84 per share, which is equal to the closing price of Kezar’s common |
Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare ConferenceKezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated |
Kezar Life Sciences Inc. (NASDAQ: KZR) Shares Are Set To Rise By 2022Kezar Life Sciences Inc. (NASDAQ:KZR) shares, rose in value on Friday, 12/30/22, with the stock price up by 0.14% to the previous day’s close as strong demand from buyers drove the stock to $7.04. Actively observing the price movement in the last trading, the stock closed the session at $7.03, falling within a range of … Kezar Life Sciences Inc. (NASDAQ: KZR) Shares Are Set To Rise By 2022 Read More » |
Have you been able to find a good deal on Kezar Life Sciences Inc.’s shares?As of Thursday, Kezar Life Sciences Inc.’s (NASDAQ:KZR) stock closed at $7.03, up from $6.60 the previous day. While Kezar Life Sciences Inc. has overperformed by 6.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, KZR fell by -56.95%, with highs and lows ranging from $18.55 […] |
KZR Price Returns
| 1-mo | 1.85% |
| 3-mo | -2.58% |
| 6-mo | -28.30% |
| 1-year | -45.60% |
| 3-year | 133.55% |
| 5-year | N/A |
| YTD | 1.85% |
| 2022 | -57.89% |
| 2021 | 220.31% |
| 2020 | 30.17% |
| 2019 | -83.01% |
| 2018 | N/A |
Loading social stream, please wait...